NFSG
HRMY icon

Newbridge Financial Services Group’s Harmony Biosciences HRMY Stock Holding History

Newbridge Financial Services Group’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-29
Closed -$950 – 1244
2023
Q3 		$950 Hold
29
– – ﹤0.01% 1162
2023
Q2 		$1.02K Hold
29
– – ﹤0.01% 1217
2023
Q1 		$947 Hold
29
– – ﹤0.01% 1278
2022
Q4 		$1.6K Hold
29
– – ﹤0.01% 1253
2022
Q3 		$1K Hold
29
– – ﹤0.01% 1300
2022
Q2 		$1K Hold
29
– – ﹤0.01% 1276
2022
Q1 		$1K Hold
29
– – ﹤0.01% 1379
2021
Q4 		$1K Hold
29
– – ﹤0.01% 1330
2021
Q3 		$1K Hold
29
– – ﹤0.01% 1267
2021
Q2 		$1K Hold
29
– – ﹤0.01% 1356
2021
Q1 		$1K Buy
+29
New +$1.02K ﹤0.01% 1276

Other funds holding HRMY

VM
Valor Management Chicago, Illinois $181M AUM 6.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Newbridge Financial Services Group's HRMY Position: Q4 2023 in Review

Newbridge Financial Services Group sold out of Harmony Biosciences (HRMY) in Q4 2023, closing a stake of 29 shares — an estimated $950 sold.

Newbridge Financial Services Group first reported a position in HRMY in Q1 2021 and held it in 11 quarters. The position peaked at $1.6K in Q4 2022. 221 funds tracked by Wall St. Rank hold HRMY as of Q4 2023.

  • Newbridge Financial Services Group reported no remaining Harmony Biosciences position as of Q4 2023 after selling out during the quarter.
  • Newbridge Financial Services Group sold 29 Harmony Biosciences shares in Q4 2023, an estimated $950.
  • Newbridge Financial Services Group first reported a position in Harmony Biosciences in Q1 2021 and held it in 11 quarters.
  • Newbridge Financial Services Group's Harmony Biosciences position peaked at $1.6K in Q4 2022.
  • 221 funds tracked by Wall St. Rank held Harmony Biosciences as of Q4 2023.

Based on Newbridge Financial Services Group's 13F filing for Q4 2023, filed 28 Mar 2024.